Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cardiogenic Shock
Interventions
DEVICE

HeartMate PHP

The HeartMate PHP system is a catheter-based heart pump and console designed to provide hemodynamic left ventricular support for up to 3 days to stabilize patients by maintaining adequate systemic cardiac output.

Trial Locations (6)

1122

Semmelweis University Heart and Vascular Center, Budapest

30625

Medizinische Hochschule Hannover, Hanover

40225

Universitätskliniken Düsseldorf, Düsseldorf

130 50

Na Homolce Hospital, Prague

140 21

Institute for Clinical and Experimental Medicine (IKEM), Prague

3000-CA

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Thoratec Corporation

INDUSTRY

lead

Abbott Medical Devices

INDUSTRY